PATENT CLAIM ANALYSIS

Application Number: 15868980
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "139100"]

Abstract:
The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for CD38, which plays an integral role in various disorders or conditions. These antibodies, accordingly, can be used to treat, for example, hematological malignancies such as multiple myeloma. Antibodies of the invention also can be used in the diagnostics field, as well as for investigating the role of CD38 in the progression of disorders associated with malignancies. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. The invention also provides isolated novel epitopes of CD38 and methods of use therefore.

Claim (Index 99):
A method of treating the overexpression of CD38 in a patient in need thereof with a therapeutically effective amount of the antibody of  claim 90 .

Metadata:
- Claim Count in Document: 19.0
- Percentile: 86.0
- Lexical Diversity: 1.77465
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14958980', '10588568', '13302195', '13291473', '14877958']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7799625469039622
- 35 USC 102 Novelty (BERT): 0.6022254448321099
- Combined Prediction Score: 0.762188836696777
- Mean Citation Score: 525.541958
- Max Citation Score: 584.1605
- Similarity Product: 419.3747641865612

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test